🇺🇸 FDA
Pipeline program

Locally Sourced 0.9% Sodium Chloride

220723

Phase 2 small_molecule active

Quick answer

Locally Sourced 0.9% Sodium Chloride for Dermatitis, Atopic is a Phase 2 program (small_molecule) at GlaxoSmithKline Biologicals S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
GlaxoSmithKline Biologicals S.A.
Indication
Dermatitis, Atopic
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials